CD274 and neoplasm: Researchers [116] developed a dual-responsive polymer complex (DRP/Res/siP) for the co-delivery of PD-L1 siRNA and Res to achieve antitumor effects by silencing PD-L1 to balance the glycolysis and mitochondrial oxidative phosphorylation of tumor cells.